Resultats de la cerca - Sachdev, Pallavi

Mapping the Ligand-binding Site on a GPCR Using Genetically-encoded Photocrosslinkers per Grunbeck, Amy, Huber, Thomas, Sachdev, Pallavi, Sakmar, Thomas P.

Obtenir text complet Obtenir text complet Obtenir text complet

CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration per Décaillot, Fabien M., Kazmi, Manija A., Lin, Ying, Ray-Saha, Sarmistha, Sakmar, Thomas P., Sachdev, Pallavi

Obtenir text complet Obtenir text complet Obtenir text complet

Vav3 Mediates Receptor Protein Tyrosine Kinase Signaling, Regulates GTPase Activity, Modulates Cell Morphology, and Induces Cell Transformation per Zeng, Liyu, Sachdev, Pallavi, Yan, Lunbiao, Chan, Joseph L., Trenkle, Thomas, McClelland, Michael, Welsh, John, Wang, Lu-Hai

Obtenir text complet Obtenir text complet

G protein βγ subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowth per Sachdev, Pallavi, Menon, Santosh, Kastner, David B, Chuang, Jen-Zen, Yeh, Ting-Yu, Conde, Cecilia, Caceres, Alfredo, Sung, Ching-Hwa, Sakmar, Thomas P

Obtenir text complet Obtenir text complet Obtenir text complet

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma per Lee, Chung-Han, Motzer, Robert J., Glen, Hilary, Michaelson, M. D., Larkin, James, Minoshima, Yukinori, Kanekiyo, Michio, Ikezawa, Hiroki, Sachdev, Pallavi, Dutcus, Corina E., Funahashi, Yasuhiro, Voss, Martin H.

Obtenir text complet Obtenir text complet Obtenir text complet

First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor per Plummer, Ruth, Dua, Divyanshu, Cresti, Nicola, Drew, Yvette, Stephens, Peter, Foegh, Marie, Knudsen, Steen, Sachdev, Pallavi, Mistry, Bipin M., Dixit, Vaishali, McGonigle, Sharon, Hall, Nancy, Matijevic, Mark, McGrath, Shannon, Sarker, Debashis

Obtenir text complet Obtenir text complet Obtenir text complet

Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells per Tchernychev, Boris, Ren, Yong, Sachdev, Pallavi, Janz, Jay M., Haggis, Lynn, O'Shea, Adam, McBride, Ed, Looby, Richard, Deng, Qing, McMurry, Thomas, Kazmi, Manija A., Sakmar, Thomas P., Hunt, Stephen, Carlson, Kenneth E.

Obtenir text complet Obtenir text complet Obtenir text complet

Phase I dose-escalation study of the multikinase inhibitor lenvatinib in patients with advanced solid tumors and in an expanded cohort of patients with melanoma per Hong, David S., Kurzrock, Razelle, Wheler, Jennifer J., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Kim, Kevin B., Davies, Michael A., Nguyen, Ly M., George, Goldy C., Xu, Lucy, Shumaker, Robert, Ren, Min, Mink, Jennifer, Bedell, Cynthia, Andresen, Corina, Sachdev, Pallavi, O'Brien, James P., Nemunaitis, John

Obtenir text complet Obtenir text complet Obtenir text complet

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer per Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio

Obtenir text complet Obtenir text complet Obtenir text complet

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE(2)-receptor E-type 4 (EP4), in patients with advanced cancers per Hong, David S, Parikh, Aparna, Shapiro, Geoffrey I, Varga, Andrea, Naing, Aung, Meric-Bernstam, Funda, Ataman, Özlem, Reyderman, Larisa, Binder, Terri A, Ren, Min, Liu, Mingjie, Dayal, Satish, Siu, Amy Y, Sachdev, Pallavi, Xu, Lucy, Bhagawati-Prasad, Vijay, Tchakov, Ilian, Ooi, Chean Eng, Bao, Xingfeng, Marabelle, Aurelien

Obtenir text complet Obtenir text complet Obtenir text complet

High response rate and durability driven by HLA genetic diversity in kidney cancer patients treated with the immunotherapy combination lenvatinib and pembrolizumab. per Lee, Chung-Han, DiNatale, Renzo G., Chowell, Diego, Krishna, Chirag, Makarov, Vladimir, Valero, Cristina, Vuong, Lynda, Lee, Mark, Weiss, Kate, Hoen, Doug, Morris, Luc, Reznik, Ed, Murray, Samuel, Kotecha, Ritesh, Voss, Martin H., Carlo, Maria I, Feldman, Darren, Sachdev, Pallavi, Adachi, Yusuke, Minoshima, Yukinori, Matsui, Junji, Funahashi, Yasuhiro, Nomoto, Kenichi, Hakimi, A. Ari, Motzer, Robert J., Chan, Timothy A.

Obtenir text complet Obtenir text complet Obtenir text complet